CN117624744A - Novel hydrogel and preparation method and application thereof - Google Patents
Novel hydrogel and preparation method and application thereof Download PDFInfo
- Publication number
- CN117624744A CN117624744A CN202311537972.XA CN202311537972A CN117624744A CN 117624744 A CN117624744 A CN 117624744A CN 202311537972 A CN202311537972 A CN 202311537972A CN 117624744 A CN117624744 A CN 117624744A
- Authority
- CN
- China
- Prior art keywords
- hydrogel
- solution
- chitosan
- component
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 229920001661 Chitosan Polymers 0.000 claims abstract description 24
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims abstract description 18
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 14
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 12
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 12
- 229940074391 gallic acid Drugs 0.000 claims abstract description 9
- 235000004515 gallic acid Nutrition 0.000 claims abstract description 9
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims abstract description 7
- 230000003647 oxidation Effects 0.000 claims abstract description 4
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 4
- 230000017423 tissue regeneration Effects 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000008367 deionised water Substances 0.000 claims description 13
- 229910021641 deionized water Inorganic materials 0.000 claims description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 230000037314 wound repair Effects 0.000 claims description 6
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 238000004132 cross linking Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims 1
- 210000001808 exosome Anatomy 0.000 abstract description 15
- 210000000130 stem cell Anatomy 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 5
- 238000010382 chemical cross-linking Methods 0.000 abstract description 3
- 239000011148 porous material Substances 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 abstract description 3
- 230000003915 cell function Effects 0.000 abstract description 2
- 230000012292 cell migration Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000007838 tissue remodeling Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- 208000031737 Tissue Adhesions Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000004402 polyphenol group Chemical group 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
- C08J2405/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
技术领域Technical field
本发明属于水凝胶材料技术领域,具体涉及一种新型水凝胶及其制备方法和应用。The invention belongs to the technical field of hydrogel materials, and specifically relates to a new type of hydrogel and its preparation method and application.
背景技术Background technique
水凝胶是一种特殊的高分子材料,具有吸水性能。它可以在接触水或其他液体时吸收和保持大量的水分,形成胶状或凝胶状的状态。是一种发展迅速的功能高分子材料,在生物医药、酶活性控制、分子分离等领域有着广泛的应用,尤其是在手术、烧伤、慢性溃疡、创面修复方面起着十分重要的作用,因为创面修复的治疗一直是临床上的主要挑战,由于传统治疗方法效果有限,一般通过缝合后的压力修复,皮瓣移植等,这些只能做表面的创面修复,对于深层的创面修复还具有一定的局限性,为了满足临床需求,还将需要开发克服这些缺点的新型水凝胶,以便于达到更好的创面治疗的效果。Hydrogel is a special polymer material with water-absorbing properties. It can absorb and retain large amounts of moisture, forming a gel-like or gel-like state when in contact with water or other liquids. It is a rapidly developing functional polymer material that is widely used in biomedicine, enzyme activity control, molecular separation and other fields. It especially plays a very important role in surgery, burns, chronic ulcers, and wound repair, because the wound surface Repair treatment has always been a major clinical challenge. Due to the limited effect of traditional treatment methods, pressure repair after suturing, skin flap transplantation, etc. can only be used for superficial wound repair, and there are certain limitations for deep wound repair. In order to meet clinical needs, new hydrogels that overcome these shortcomings will need to be developed to achieve better wound treatment effects.
为预防创面或者伤口感染,抗菌敷料是必不可少的;同时黏附性对水凝胶来说也是十分重要的,有很好的粘附性可以让其黏附在患者患处的表面,能进行长期持久的治疗;然后,大多数的水凝胶在较长时间使用后会造成氧化而失去原本具有的性能,所以在这些方面还有待提高。In order to prevent wounds or wound infections, antibacterial dressings are indispensable; at the same time, adhesion is also very important for hydrogels. Good adhesion allows them to adhere to the surface of the patient's affected area and can be used for a long time. treatment; however, most hydrogels will oxidize and lose their original properties after being used for a long time, so there is still room for improvement in these aspects.
发明内容Contents of the invention
为了解决上述技术问题,本发明提供了一种新型水凝胶及其制备方法和应用,可将干细胞源的外泌体负载在没食子酸修饰的壳聚糖,(以下简称CSGA)和醛基化透明质酸(以下简称HA-ALD)的动态化学交联水凝胶中,从而制备了可缓释释放外泌体的多功能水凝胶敷料,该水凝胶具备多种优异特性,包括良好的机械性能、组织粘附性、光谱抗菌活性和抗氧化能力它加速表皮再生和真皮结构重建,这种多种功能水凝胶敷料,以下简称ECGH为创面修复的治疗提供了新的选择;同时也为干细胞外泌体在组织工程学中的应用拓展了新的可能性。In order to solve the above technical problems, the present invention provides a new type of hydrogel and its preparation method and application, which can load stem cell-derived exosomes on gallic acid-modified chitosan (hereinafter referred to as CSGA) and aldehyde Dynamic chemical cross-linking hydrogel of hyaluronic acid (hereinafter referred to as HA-ALD) was used to prepare a multifunctional hydrogel dressing that can sustainably release exosomes. The hydrogel has a variety of excellent properties, including good With its mechanical properties, tissue adhesion, spectrum antibacterial activity and antioxidant capacity, it accelerates epidermal regeneration and dermal structure reconstruction. This multi-functional hydrogel dressing, hereinafter referred to as ECGH, provides a new option for wound repair treatment; at the same time It also expands new possibilities for the application of stem cell exosomes in tissue engineering.
为了达到上述技术效果,一方面,本发明公开了一种新型水凝胶,包括:第一组分、第二组分;所述第一组分包括没食子酸修饰的壳聚糖或其衍生物;所述第二组分包括醛基化透明质酸或其衍生物;所述第一组分和第二组分通过化学动态交联,反应交联的比例为1:1~1:2之间;In order to achieve the above technical effects, on the one hand, the present invention discloses a new type of hydrogel, including: a first component and a second component; the first component includes gallic acid-modified chitosan or its derivatives ; The second component includes aldehyde hyaluronic acid or its derivatives; the first component and the second component are chemically dynamically cross-linked, and the ratio of reaction cross-linking is between 1:1 and 1:2. between;
另一方面,本发明提供了一种新型水凝胶的制备方法,包括以下步骤:On the other hand, the present invention provides a method for preparing a novel hydrogel, which includes the following steps:
S1:用4-8M的HCl调节壳聚糖pH至4-6后溶于去离子水中,形成1.5wt%的壳聚糖溶液;S1: Use 4-8M HCl to adjust the pH of chitosan to 4-6 and then dissolve it in deionized water to form a 1.5wt% chitosan solution;
S2:将S1中得到的壳聚糖溶液在水浴中加热至50-70℃,并使用N2脱氧10min,然后在壳聚糖溶液中加入没食子酸反应;S2: Heat the chitosan solution obtained in S1 to 50-70°C in a water bath, and use N2 to deoxidize for 10 minutes, then add gallic acid to the chitosan solution for reaction;
S3:将EDC和NHS溶解在比例为1:1~1:2乙醇和水的混合物中,后将该混合物滴加到S2中所得的混合溶液中,并保持pH为4-6在N2环境下反应12-24h;S3: Dissolve EDC and NHS in a mixture of ethanol and water in a ratio of 1:1 to 1:2, and then add the mixture dropwise to the mixed solution obtained in S2, and keep the pH at 4-6 in a N2 environment Reaction 12-24h;
S4:将S3中得到的溶液在含NaCl的酸化去离子水中透析4-7天,抑制儿茶酚基团的氧化;之后进行冷冻、干燥,得到没食子酸改性壳聚糖CS-GA;S4: Dialyze the solution obtained in S3 in acidified deionized water containing NaCl for 4-7 days to inhibit the oxidation of the catechol group; then freeze and dry to obtain gallic acid-modified chitosan CS-GA;
S5:取一定量的透明质酸溶解于去离子水中,搅拌均匀后向其中加入一定量的高碘酸钠并在避光条件下反应3-5h;S5: Dissolve a certain amount of hyaluronic acid in deionized water, stir evenly, add a certain amount of sodium periodate and react for 3-5 hours under dark conditions;
S6:向S5中反应后的溶液中加入乙二醇终止反应,继续搅拌2-4h;减半完成后将所得到的溶液在去离子水中透析4天,最后冷冻、干燥,得到醛基化的透明质酸HA-ALD;S6: Add ethylene glycol to the solution reacted in S5 to terminate the reaction, and continue stirring for 2-4 hours; after halving, dialyze the resulting solution in deionized water for 4 days, and finally freeze and dry to obtain aldehyde. Hyaluronic acid HA-ALD;
S7:取一定量的hUCMSCs-Exo加入4%HA-ALD中,超声混匀后;然后,将上述溶液与3wt%的CS-GA溶液以体积比为1:1~1:2的比例震荡混合;混合均匀后得到可注射的Exo@CsGA-HA水凝胶。S7: Add a certain amount of hUCMSCs-Exo to 4% HA-ALD, and mix evenly with ultrasonic; then, shake and mix the above solution with 3wt% CS-GA solution in a volume ratio of 1:1 to 1:2. ; After mixing evenly, an injectable Exo@CsGA-HA hydrogel is obtained.
第三方面,本发明提供了一种新型水凝胶的应用,将干细胞源的外泌体负载在本水凝胶中,由于CSGAHA可形成孔隙结构,外泌体能负载进入,制备可缓释释放外泌体的多功能水凝胶敷料。In the third aspect, the present invention provides the application of a new type of hydrogel. Exosomes derived from stem cells are loaded into the hydrogel. Since CSGAHA can form a pore structure, the exosomes can be loaded into the hydrogel, and the preparation can be sustained-released. Multifunctional hydrogel dressing based on exosomes.
本发明的有益效果是:The beneficial effects of the present invention are:
本发明制备合成了一种具有良好的粘附性、可注射性、广谱抗菌性、抗氧化性的新型水凝胶,并且通过制备后的没食子酸修饰的壳聚糖和醛基化透明质酸的动态化学交联水凝胶,可以将干细胞源的外泌体负载在其中,可以达到外泌体的缓慢释放的效果;其次,本发明的水凝胶的孔隙结构及分子特点优越,有助于细胞迁移和组织再生,为增强细胞功能和为创面修复的治疗提供了新的选择,同时也为干细胞外泌体在组织工程学中的应用拓展了新的可能性。The present invention prepares and synthesizes a new type of hydrogel with good adhesion, injectability, broad-spectrum antibacterial properties and antioxidant properties, and uses the prepared gallic acid-modified chitosan and aldehylated hyaluronic acid to The dynamic chemical cross-linking hydrogel of acid can load stem cell-derived exosomes in it, and can achieve the effect of slow release of exosomes; secondly, the hydrogel of the present invention has superior pore structure and molecular characteristics, and has It helps cell migration and tissue regeneration, provides new options for enhancing cell function and wound repair treatment, and also expands new possibilities for the application of stem cell exosomes in tissue engineering.
附图说明Description of drawings
为了更清楚地说明本发明实施例的技术方案,下面将对实施例描述所需要使用的附图作简单地介绍。In order to explain the technical solutions of the embodiments of the present invention more clearly, the drawings required for describing the embodiments will be briefly introduced below.
图1是水凝胶冻干后的形貌图;Figure 1 is a morphology diagram of the hydrogel after freeze-drying;
图2是FTIR法测量后得到的波数和吸收强度示意图;Figure 2 is a schematic diagram of the wave number and absorption intensity obtained after measurement by FTIR method;
图3是测量zeta电位图。Figure 3 is a diagram of measured zeta potential.
具体实施方式Detailed ways
实施例1Example 1
在本实施例中,提供了一种新型水凝胶的制备方法,包括以下步骤:In this embodiment, a method for preparing a novel hydrogel is provided, which includes the following steps:
S1:用4-8M的HCl调节壳聚糖pH至4-6后溶于去离子水中,形成1.5wt%的壳聚糖溶液;S1: Use 4-8M HCl to adjust the pH of chitosan to 4-6 and then dissolve it in deionized water to form a 1.5wt% chitosan solution;
S2:将S1中得到的壳聚糖溶液在水浴中加热至50-70℃,并使用N2脱氧10min,然后在壳聚糖溶液中加入没食子酸反应;加入的没食子酸的质量为100-150mg之间;S2: Heat the chitosan solution obtained in S1 to 50-70°C in a water bath, and use N2 to deoxidize for 10 minutes, then add gallic acid to the chitosan solution for reaction; the mass of gallic acid added is 100-150mg between;
S3:将EDC和NHS溶解在比例为1:1~1:2的乙醇和水的混合物中,后将该混合物滴加到S2中所得的混合溶液中,并保持pH为4-6在N2环境下反应12-24h;混合的乙醇和水的体积为50-70ml。S3: Dissolve EDC and NHS in a mixture of ethanol and water with a ratio of 1:1 to 1:2, and then add the mixture dropwise to the mixed solution obtained in S2, and maintain the pH at 4-6 in a N2 environment React for 12-24h; the volume of mixed ethanol and water is 50-70ml.
S4:将S3中得到的溶液在含NaCl的酸化去离子水中透析4-7天,抑制儿茶酚基团的氧化;之后进行冷冻、干燥,得到没食子酸改性壳聚糖;S4: Dialyze the solution obtained in S3 in acidified deionized water containing NaCl for 4-7 days to inhibit the oxidation of the catechol group; then freeze and dry to obtain gallic acid-modified chitosan;
S5:取一定量的透明质酸溶解于去离子水中,搅拌均匀后向其中加入一定量的高碘酸钠并在避光条件下反应3-5h;具体的过程为,将1g透明质酸(HA)溶解于120mL去离子水中,搅拌均匀后向其中加入1g的高碘酸钠(NaIO4),在避光条件下反应3-5h;S5: Dissolve a certain amount of hyaluronic acid in deionized water, stir evenly, then add a certain amount of sodium periodate and react under light-proof conditions for 3-5 hours; the specific process is to dissolve 1g of hyaluronic acid ( HA) was dissolved in 120 mL of deionized water, stir evenly and then add 1 g of sodium periodate (NaIO4) to it, and react for 3-5 hours under dark conditions;
S6:向S5中反应后的溶液中加入乙二醇终止反应,继续搅拌2-4h;减半完成后将所得到的溶液在去离子水中透析4天,最后冷冻、干燥,得到醛基化的透明质酸;利用乙二醇终止反应的体积量在3-5ml之间;S6: Add ethylene glycol to the solution reacted in S5 to terminate the reaction, and continue stirring for 2-4 hours; after halving, dialyze the resulting solution in deionized water for 4 days, and finally freeze and dry to obtain aldehyde. Hyaluronic acid; the volume of ethylene glycol to terminate the reaction is between 3-5ml;
S7:100ug hUCMSCs-Exo加入4%HA-ALD中,超声混匀后;然后,将上述溶液与3wt%的CS-GA溶液以体积比1:1~1:2震荡混合;混合均匀后得到可注射Exo@CsGA-HA水凝胶。S7: 100ug hUCMSCs-Exo is added to 4% HA-ALD, and mixed evenly by ultrasonic; then, the above solution is shaken and mixed with 3wt% CS-GA solution at a volume ratio of 1:1 to 1:2; after mixing evenly, the product can be obtained Injection of Exo@CsGA-HA hydrogel.
实施例2Example 2
在本实施例中,首先,通过EDC/NHS方法合成了CS-GA。在EDC/NHS的活化下,没食子酸中的羧基和壳聚糖中的氨基之间反应形成酰胺键。接下来通过使用高碘酸钠对透明质酸链上的羟基进行氧化,合成了醛基修饰的透明质酸(HA-ALD),100ug hUCMSCs-Exo加入4%HA-ALD中,超声混匀后;然后,将上述溶液与3wt%的CS-GA溶液以体积比1:1~1:2得到Exo@CsGA-HA水凝胶。如图2所示,以FTIR测得ECGH水凝胶出现特征吸收带,说明没食子酸成功地与壳聚糖骨架缀合,同时没食子酸修饰解决了壳聚糖水溶性不佳的问题。此外,由于没食子酸上具有多酚基团,改性后的壳聚糖赋予了水凝胶敷料出色的止血性、组织粘附性、抗菌性和抗氧化性能。In this example, first, CS-GA was synthesized by the EDC/NHS method. Under the activation of EDC/NHS, the carboxyl group in gallic acid and the amino group in chitosan react to form an amide bond. Next, aldehyde-modified hyaluronic acid (HA-ALD) was synthesized by using sodium periodate to oxidize the hydroxyl groups on the hyaluronic acid chain. 100ug hUCMSCs-Exo was added to 4% HA-ALD, and mixed with ultrasonic ; Then, the above solution was mixed with 3wt% CS-GA solution at a volume ratio of 1:1 to 1:2 to obtain Exo@CsGA-HA hydrogel. As shown in Figure 2, the ECGH hydrogel showed characteristic absorption bands measured by FTIR, indicating that gallic acid was successfully conjugated to the chitosan backbone, and the gallic acid modification solved the problem of poor water solubility of chitosan. In addition, due to the polyphenol groups on gallic acid, the modified chitosan endows the hydrogel dressing with excellent hemostatic, tissue adhesion, antibacterial and antioxidant properties.
实施例3Example 3
在本实施例中,提供Exo@CsGA-HA水凝胶的应用,将干细胞源的外泌体负载在本水凝胶中,制备了可缓释释放外泌体的多功能水凝胶敷料,将该多功能水凝胶敷料贴附到皮肤创面的表面,贴附时长为2-3天,之后换上新的负载干细胞的源外泌体的水凝胶,以重复三次为一个疗程,坚持两个疗程,患者的创面皮肤有明显的改善,同时,不会对患者造成影响,舒适度高,在一定程度上给有深创面的患者提供了一种新的治疗途径。In this embodiment, the application of Exo@CsGA-HA hydrogel is provided. Stem cell-derived exosomes are loaded into the hydrogel to prepare a multifunctional hydrogel dressing that can sustainably release exosomes. The multifunctional hydrogel dressing is attached to the surface of the skin wound for 2-3 days, and then replaced with a new hydrogel loaded with exosomes derived from stem cells. Repeat three times as a course of treatment. After two courses of treatment, the patient's wound skin has been significantly improved. At the same time, it will not affect the patient and is highly comfortable. To a certain extent, it provides a new treatment approach for patients with deep wounds.
以上公开的本发明优选实施例只是用于帮助阐述本发明,优选实施例并没有详尽叙述所有的细节,也不限制该发明仅为所述的具体实施方式。The preferred embodiments of the present invention disclosed above are only used to help explain the present invention. The preferred embodiments do not describe all the details in detail, nor do they limit the invention to the specific implementations described.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311537972.XA CN117624744A (en) | 2023-11-17 | 2023-11-17 | Novel hydrogel and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311537972.XA CN117624744A (en) | 2023-11-17 | 2023-11-17 | Novel hydrogel and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117624744A true CN117624744A (en) | 2024-03-01 |
Family
ID=90027920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311537972.XA Pending CN117624744A (en) | 2023-11-17 | 2023-11-17 | Novel hydrogel and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117624744A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119345450A (en) * | 2024-10-22 | 2025-01-24 | 中国人民解放军空军特色医学中心 | Preparation method of pH intelligent responsive hydrogel and pH intelligent responsive hydrogel |
-
2023
- 2023-11-17 CN CN202311537972.XA patent/CN117624744A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119345450A (en) * | 2024-10-22 | 2025-01-24 | 中国人民解放军空军特色医学中心 | Preparation method of pH intelligent responsive hydrogel and pH intelligent responsive hydrogel |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113372585A (en) | Preparation method and application of hydrogel with high-adhesion composite function | |
| CN114767919B (en) | Hydrogel powder for rapid hemostasis as well as preparation method and application thereof | |
| CN106496608B (en) | Collagen-based compounds the preparation method of non-ionic polysaccharide building composite hydrogel | |
| Yang et al. | Injectable polylysine and dextran hydrogels with robust antibacterial and ROS-scavenging activity for wound healing | |
| CN105288704B (en) | A kind of polyamide-amide dendrimer modification of chitosan wound repair hydrogel and its preparation method and application | |
| CN108498847A (en) | Macromolecule hydrogel, preparation method based on acylhydrazone key and skin histology adhesive | |
| CN114887110B (en) | Hemostatic material capable of quickly stopping bleeding and preparation method thereof | |
| CN114848668A (en) | Composition with wound healing promoting and quick hemostasis functions | |
| Xu et al. | Etamsylate loaded oxidized Konjac glucomannan-ε-polylysine injectable hydrogels for rapid hemostasis and wound healing | |
| CN116178751A (en) | Self-healing hydrogel and preparation method thereof | |
| CN115554462A (en) | Anti-swelling injectable hydrogel adhesive and preparation method thereof | |
| CN115536919A (en) | Modified chitosan adhesive hydrogel and preparation method and application thereof | |
| CN116747344A (en) | Dialdehyde starch crosslinked amino gelatin hemostatic sponge and preparation method thereof | |
| CN117624744A (en) | Novel hydrogel and preparation method and application thereof | |
| CN114470313A (en) | Bionic mechanical activity hydrogel adhesive and preparation method thereof | |
| CN112143410B (en) | Injectable biological adhesive and preparation method and application thereof | |
| CN107261199A (en) | A kind of preparation method of the gel dressing containing Zeolite hemostatic | |
| CN115887745B (en) | A hemostatic hydrogel and its preparation method and application | |
| Sun et al. | A multifunctional semi-interpenetrating polymer network hydrogel dressing for wound healing | |
| CN107349464B (en) | A kind of preparation method of novel medical hemostatic gel dressing | |
| CN116392629B (en) | A multifunctional hydrogel dressing and its preparation method and application | |
| CN108452366A (en) | A kind of gelatin-compounded bleeding-stopping dressing of cod skin and preparation method thereof | |
| CN116159192B (en) | Injectable hemostatic anti-adhesion hydrogel and preparation method thereof | |
| CN114748677B (en) | Anti-adhesion hydrogel adhesive, and preparation method and application thereof | |
| CN118580173A (en) | Functionally modified bio-based material and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |